Distribution of Fortified Yoghurt in Senegal to Decrease Children's Anemia and Improve Milk Supply

NCT02079961 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 471

Last updated 2014-03-06

No results posted yet for this study

Summary

The study on dairy value chains that will be conducted in Northern Senegal tests whether a health-related product (micro-fortified yogurt) targeted to children can be provided through the logistics of an existing value chain, and whether in return this can be leveraged to enhance the reliability of producers supply within this value chain. This study is conducted with a local milk factory, a recently established social enterprise, striving to produce dairy products with the milk collected from several hundred semi-nomadic small-scale producers in northern Senegal. This study tests: (i) whether the logistic created to collect milk in a remote area can be leveraged to deliver fortified yogurts to infants within its suppliers households; (ii) whether such products effectively help improve the nutritional status (anemia) of these children; and (iii) whether these health services encourage suppliers (and in particular women) to increase their milk delivery to the milk factory.

Conditions

Interventions

DIETARY_SUPPLEMENT

Micronutrient-fortified yoghurt

A iron-fortified yogurt targeted to children 24-59 months old will be provided through the logistics of an existing value chain, to see if in return this can enhance the reliability of producers supply within this value chain.

BEHAVIORAL

BCC

Behavior Change Campaign (BCC) A behavior change campaign will be conducted during all the duration of the intervention to increase knowledge about good infant feeding practices and health.

Sponsors & Collaborators

  • GRET

    collaborator UNKNOWN
  • Cellule de Lutte contre la Malnutrition

    collaborator UNKNOWN
  • Universite Gaston Berger

    collaborator UNKNOWN
  • Agnes LePort

    lead OTHER

Principal Investigators

  • Rahul Rawat, PhD · IFPRI

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
24 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-02-28
Completion
2014-03-31

Countries

  • Senegal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02079961 on ClinicalTrials.gov